Aicardi Goutieres Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Aicardi Goutieres Syndrome trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Aicardi Goutieres Syndrome trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The primary objective of this study is to assess safety as well as efficacy of baricitinib, a Janus Kinase (JAK) inhibitor, in patients with Aicardi Goutières S…
Leukodystrophies, and other heritable disorders of the white matter of the brain, were previously resistant to genetic characterization, largely due to the extr…